NAS10027,087+1.72%S&P7,401+0.65%GOLD$4,073−1.00%BTC$75,828−0.15%VIX24.55−12.88%latest tape · as of 20:03 UTC
The Screen · Industrials · Specialty Industrial Machinery
Regal Rexnord Corp
RRX · the NYSE · USD · Market cap $10.0B · 30,000 employees
Regal Rexnord Corporation provides sustainable solutions for power, transmit, and control motion products in the North America, Asia, Europe, and internationally.
FAIL · Does not pass the screen
160.30 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price160.30 USD at the 5 Nov 2026 close
Our value readUndervalued vs our fair value, as of 5 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.15, read 2026-11-02
Ethical does not pass the values gate
Price160.30 USD
Fair value243.97
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-11-01Read Markup157.24+1.9% to today ✓Markdown gives way to Markup
2026-10-27Read Markdown150.48+6.5% to today Accumulation gives way to Markdown after a 6% slide in 2 weeks
2026-10-11Read Accumulation160.01+0.2% to today ✓Markdown gives way to Accumulation
2026-09-11Read Markdown160.77-0.3% to today ✓Distribution gives way to Markdown after a 24% slide in 10 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Regal Rexnord Corp holds its Markup at $160.30. The statistical read favours the sellers, held for 41 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 41 days
Price at the screen
$160.30
Valuation
30.96 trailing · 11.65 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.07
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
35.49%
Below 33%
Interest-bearing debt is 35.5% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
7.51%
Below 49%
Money owed to the company is 7.5% of assets, under the 49% limit.
Pass
Revenue purity
0.40%
Below 5%
Only 0.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Regal Rexnord's business is in a permissible area, but its interest-bearing debt is about 35% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when RRX's ethical verdict changes
Today RRX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 29% discount to our $243.97 fair value, narrow competitive moat, 4.20% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 34.3% discount to the base estimate.
Where our models see it going: fair-value estimate $243.97, with a range of $193.83 to $323.05, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Factory Motors That Fail to Turn Heads
Every factory line depends on the gears and motors that shift power from one station to the next. Regal Rexnord sits in that space yet posts revenue growth of just 4 percent, a 5 percent profit margin and 4 percent return on equity. We pass because those returns sit too low for a narrow moat business trading at 15.3 times forward earnings.
The shares trade at 206 dollars against our 264 dollar fair value, a 28 percent margin of safety, and nine analysts carry a strong buy call with a 260 dollar median target. Still the numbers point to a company that does not compound capital efficiently enough to justify ownership.
Risk sits in the narrow competitive position that leaves it open to larger rivals and in the low returns that suggest any upturn could prove fleeting. The ethical screen clears, yet the opportunity does not appear. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
RRX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-03Markup$157.24+0.0%Entry 17
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markup$157.24+0.0%Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markup · changed$157.24+4.5%Entry 15
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Markdown$150.48+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Markdown$150.48+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Markdown$150.48+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markdown$150.48+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markdown · changed$150.48-4.2%Entry 10
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$157.06+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252.
2026-10-18Accumulation$157.06-1.8%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it strong buy, with a mean price target of $252.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
